NICE guidance on continuous subcutaneous insulin infusion 2008: Review of the technology appraisal guidance

Diabetic Medicine

Volumn 26, Issue 1, 2009, Pages 1-4

  Pickup, J C ^a   Hammond, P ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b HARROGATE DISTRICT HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; EDITORIAL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; QUALITY OF LIFE;

ADOLESCENT; ADULT; CHILD; DIABETES MELLITUS, TYPE 1; GOVERNMENT AGENCIES; GREAT BRITAIN; GUIDELINES AS TOPIC; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INSULIN; YOUNG ADULT;

EID: 58149235096     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02617.x     Document Type: Editorial

References (22)

1. National Institute for Health and Clinical Excellence. Continuous Subcutaneous Insulin Infusion for the Treatment of Diabetes Mellitus. Technology Appraisal Guidance 151 (Review of Technology Appraisal Guidance 57). London : NICE, 2008.
2. National Institute for Clinical Excellence. Guidance on the use of continuous subcutaneous insulin infusion for diabetes. Technology Appraisal Guidance No. 57. London : NICE, 2003.
3. Pickup JC, Mattock MB, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared to intensive insulin injection therapy in type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 2002 324 : 705 708.
4. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy. A meta-analysis. Diabetes Care 2003 26 : 1079 1087.
5. Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections versus continuous subcutaneous insulin infusion. Diabet Med 2008 25 : 765 774.
6. Pickup JC, Kidd J, Burmiston S, Yemane N. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabet Metab Res Rev 2006 22 : 232 237.
7. Hammond P. NICE guidance on insulin pump therapy: time for a re-appraisal? Pract Diabet Int 2005 22 : 115 116.
8. Retnakaran R, Hochman J, DeVries JH, Hanaire-Broutin H, Heine RJ, Melki V et al. Continuous subcutaneous insulin infusion versus multiple daily injections. The impact of baseline A1c. Diabetes Care 2004 27 : 2590 2596.
9. Pickup JC. Are insulin pumps underutilized in type 1 diabetes? Yes. Diabetes Care 2006 29 : 1449 1452.
10. Pickup JC, Kidd J, Burmiston S, Yemane N. Effectiveness of continuous subcutaneous insulin infusion in hypoglycaemia-prone type 1 diabetes: implications for NICE guidelines. Pract Diabet Int 2005 22 : 10 14.
11. American Diabetes Association Working Group on Hypoglycemia. Defining and reporting hypoglycemia in diabetes. Diabetes Care 2005 28 : 1245 1249.
12. Scuffham P, Carr L. The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes. Diabet Med 2003 20 : 586 593.
13. Roze S, Valentine WJ, Zakrzewska KE, Palmer AJ. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of type 1 diabetes in the UK. Diabet Med 2005 22 : 1239 1245.
14. Linkeschova R, Raoul M, Bott U, Berger M, Spraul M. Less severe hypoglycaemia, better metabolic control, and improved quality of life in type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years. Diabet Med 2002 19 : 746 751.
15. McMahon SK, Airey FL, Marangou DA, McElwee KJ, Carne CL, Clarey AJ et al. Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life. Diabet Med 2005 22 : 92 96.
16. Raskin P, Bode BW, Marks JB, Hirsch IB, Weinstein RL, McGill JB et al. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. Diabetes Care 2003 26 : 2598 2603.
17. Herman WH, Ilag LL, Johnson SL, Martin CL, Sinding J, Al Harthi A et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 2005 28 : 1568 1573.
18. Wainstein J, Metzger M, Boas M, Minuchin O, Cohen Y, Yaffe A et al. Insulin pump therapy vs. multiple daily injections in obese type 2 diabetic patients. Diabet Med 2005 22 : 1037 1046.
19. Nielsen S, Kain D, Szudzik E, Dhindsa S, Garg R, Dandona P. Use of continuous subcutaneous insulin infusion pump in patients with type 2 diabetes mellitus. Diabetes Educ 2005 31 : 843 848.
20. National Institute for Health and Clinical Excellence. Diabetes in Pregnancy Clinical Guideline 63. London : NICE, 2008.
21. National Institute for Health and Clinical Excellence. Continuous Subcutaneous Insulin Infusion for the Treatment of Diabetes Mellitus. Costing Template and Report. Implementing NICE Guidance. London : NICE, 2008.
22. Department of Health/Diabetes UK. Insulin Pump Services: report of the Insulin Pump Working Group. London : Dept of Health, 2007.